Peter M. Anderson

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “Identifying States of Collateral Sensitivity during the Evolution of Therapeutic Resistance in Ewing's Sarcoma”.

Identifying States of Collateral Sensitivity during the Evolution of Therapeutic Resistance in Ewing's Sarcoma

iScience(2020)10.1016/j.isci.2020.101293

N/A

1.1DataRank · unranked

40 citations

Erin McClure, Peter M. Anderson, Andrew Dhawan, Arda Durmaz, Stephen L. Lessnick +3 more

Open-Label, Multicenter, Phase I/II, First-in-Human Trial of TK216: A First-Generation EWS::FLI1 Fusion Protein Antagonist in Ewing Sarcoma

Journal of Clinical Oncology(2024)10.1200/jco.24.00020

N/A

0.869DataRank · unranked

38 citations

Noah Federman, Najat C. Daw, Peter M. Anderson, Lara E. Davis, AeRang Kim +9 more

IGF-1R/mTOR Targeted Therapy for Ewing Sarcoma: A Meta-Analysis of Five IGF-1R-Related Trials Matched to Proteomic and Radiologic Predictive Biomarkers

Cancers(2020)10.3390/cancers12071768

N/A

0.542DataRank · unranked

36 citations

Ajaykumar C. Morani, Najat C. Daw, Salah-Eddine Lamhamedi-Cherradi, Vivek Subbiah, Brian A. Menegaz +22 more

Current and future targeted alpha particle therapies for osteosarcoma: Radium-223, actinium-225, and thorium-227

Frontiers in Medicine(2022)10.3389/fmed.2022.1030094

N/A

0.506DataRank · unranked

10 citations

Vivek Subbiah, Matteo Trucco, Peter M. Anderson

Identifying states of collateral sensitivity during the evolution of therapeutic resistance in Ewing’s sarcoma

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.02.11.943936

N/A

0DataRank · unranked

7 citations

Erin McClure, Peter M. Anderson, Andrew Dhawan, Arda Durmaz, Stephen L. Lessnick +3 more

Sodium fluoride (Na18F) PET Response Criteria in Solid Tumors (NAFCIST): a framework for response assessment in bone tumors

ESMO Open(2023)10.1016/j.esmoop.2023.101575

N/A

0DataRank · unranked

2 citations

Mohamed A. Gouda, Lars Buschhorn, Adam Wahida, Homer A. Macapinlac, Peter M. Anderson +2 more

Neutrophil to lymphocyte ratio (NTLR) predicts local control and overall survival after stereotactic body radiotherapy (SBRT) in metastatic sarcoma

Scientific Reports(2023)10.1038/s41598-023-46476-3

N/A

0DataRank · unranked

1 citations

Peter M. Anderson, Timothy D. Smile, Ahmed Halima, James B. Broughman, C.A. Reddy +13 more

Neutrophil to Lymphocyte Ratio (NTLR) Predicts Local Control Failure and Overall Survival after Stereotactic Body Radiotherapy (SBRT) in Metastatic Sarcoma

Research Square(2023)10.21203/rs.3.rs-2570832/v1

N/A

0DataRank · unranked

0 citations

Timothy D. Smile, Ahmed Halima, James B. Broughman, C.A. Reddy, Shireen Parsai +13 more